Question

Will bimagrumab be approved for the treatment of obesity by the FDA or EMA by 2029?

1 comment1

Total Forecasters21

Community Prediction32.6% (26% - 35%)

Make a Prediction

50%

community: 32.6%

Learn more about scores here.

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

2021-2025 Leaderboard

Food and Drug Administration

Novo Nordisk’s next-generation weight-loss drug CagriSema matches Lilly’s Zepbound in major trial, but doesn’t surpass it

CNN•Dec 20, 2024

Novo Nordisk shares plummet after weight-loss drug’s disappointing trial results

New York Post•Dec 21, 2024

US FDA says Lilly’s weight-loss drug shortage is resolved

CNN•Dec 20, 2024

Learn more about Metaculus NewsMatch

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

59.7%

Comments

? comments

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

2021-2025 Leaderboard

Food and Drug Administration

Novo Nordisk’s next-generation weight-loss drug CagriSema matches Lilly’s Zepbound in major trial, but doesn’t surpass it

CNN•Dec 20, 2024

Novo Nordisk shares plummet after weight-loss drug’s disappointing trial results

New York Post•Dec 21, 2024

US FDA says Lilly’s weight-loss drug shortage is resolved

CNN•Dec 20, 2024

Learn more about Metaculus NewsMatch

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

59.7%

Take Our 🏆Quarterly Cup🏆 Survey

MetaculusM

Will bimagrumab be approved for the treatment of obesity by the FDA or EMA by 2029?

Make a Prediction

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Comments

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?